title: Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
abstract: High molecular weight kininogen (HK) and factor XII are known to bind to human umbilical vein endothelial cells (HUVEC) in a zinc-dependent and saturable manner indicating that HUVEC express specific binding site(s) for those proteins. However, identification and immunochemical characterization of the putative receptor site(s) has not been previously accomplished. In this report, we have identified a cell surface glycoprotein that is a likely candidate for the HK binding site on HUVECs. When solubilized HUVEC membranes were subjected to an HK-affinity column in the presence or absence of 50 microM ZnCl2 and the bound membrane proteins eluted, a single major protein peak was obtained only in the presence of zinc. SDS/PAGE analysis and silver staining of the protein peak revealed this protein to be 33 kDa and partial sequence analysis matched the NH2 terminus of gC1q-R, a membrane glycoprotein that binds to the globular "heads" of C1q. Two other minor proteins of approximately 70 kDa and 45 kDa were also obtained. Upon analysis by Western blotting, the 33-kDa band was found to react with several monoclonal antibodies (mAbs) recognizing different epitopes on gC1q-R. Ligand and dot blot analyses revealed zinc-dependent binding of biotinylated HK as well as biotinylated factor XII to the isolated 33-kDa HUVEC molecule as well as recombinant gC1q-R. In addition, binding of 125I-HK to HUVEC cells was inhibited by selected monoclonal anti-gC1q-R antibodies. C1q, however, did not inhibit 125I-HK binding to HUVEC nor did those monoclonals known to inhibit C1q binding to gC1q-R. Taken together, the data suggest that HK (and factor XII) bind to HUVECs via a 33-kDa cell surface glycoprotein that appears to be identical to gC1q-R but interact with a site on gC1q-R distinct from that which binds C1q.
authors.affiliation: Department of Medicine, State University of New York, Stony Brook 11794-8161, USA.
authors.forename: K
authors.initials: K
authors.lastname: Joseph
authors.forename: B
authors.initials: B
authors.lastname: Ghebrehiwet
authors.forename: E I
authors.initials: EI
authors.lastname: Peerschke
authors.forename: K B
authors.initials: KB
authors.lastname: Reid
authors.forename: A P
authors.initials: AP
authors.lastname: Kaplan
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D001777:Blood Coagulation; D002352:Carrier Proteins; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism; D005174:Factor XII / Q000378:metabolism*; D006801:Humans; D018960:Hyaluronan Receptors; D007704:Kininogens / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000378:metabolism; D024101:Mitochondrial Proteins; D008970:Molecular Weight; D011485:Protein Binding; D011951:Receptors, Complement / Q000378:metabolism*; D011994:Recombinant Proteins; D015032:Zinc
chemical_list: D000911:Antibodies, Monoclonal; C087299:C1QBP protein, human; D002352:Carrier Proteins; D018960:Hyaluronan Receptors; D007704:Kininogens; D008562:Membrane Glycoproteins; D024101:Mitochondrial Proteins; D011951:Receptors, Complement; D011994:Recombinant Proteins; C032402:complement 1q receptor; D005174:Factor XII; D015032:Zinc